Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06GMG
|
|||
Drug Name |
Etoposide
|
|||
Synonyms |
etoposide; 33419-42-0; VePesid; Toposar; trans-Etoposide; Lastet; (-)-Etoposide; Zuyeyidal; Etoposido; Etoposidum; Etoposidum [INN-Latin]; VP-16; Etoposide (VP16); VP 16-213; VP 16 (pharmaceutical); Vepesid J; Etoposido [INN-Spanish]; Etopophos (phosphate salt); VP 16; VP-16-213; VP 16213; UNII-6PLQ3CP4P3; NK 171; NSC-141540; NSC 141540; CCRIS 2392; HSDB 6517; EINECS 251-509-1; Epipodophyllotoxin VP-162; Etoposide
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Testicular cancer [ICD-11: 2C80; ICD-9: 186] | Approved | [1] | |
Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Phase 2 | [2] | ||
Therapeutic Class |
Antiviral Agents
|
|||
Structure |
Download2D MOL |
|||
Formula |
C29H32O13
|
|||
Canonical SMILES |
CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
|
|||
InChI |
1S/C29H32O13/c1-11-36-9-20-27(40-11)24(31)25(32)29(41-20)42-26-14-7-17-16(38-10-39-17)6-13(14)21(22-15(26)8-37-28(22)33)12-4-18(34-2)23(30)19(5-12)35-3/h4-7,11,15,20-22,24-27,29-32H,8-10H2,1-3H3/t11-,15+,20-,21-,22+,24-,25-,26-,27-,29+/m1/s1
|
|||
InChIKey |
VJJPUSNTGOMMGY-MRVIYFEKSA-N
|
|||
CAS Number |
CAS 33419-42-0
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:4911
|
References | Top | |||
---|---|---|---|---|
REF 1 | FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (ANDA) 075635. | |||
REF 2 | ClinicalTrials.gov (NCT04356690) Etoposide in Patients With COVID-19 Infection. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.